These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7697907)

  • 1. ANCA--pathophysiology revisited.
    Kallenberg CG; Brouwer E; Mulder AH; Stegeman CA; Weening JJ; Tervaert JW
    Clin Exp Immunol; 1995 Apr; 100(1):1-3. PubMed ID: 7697907
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes.
    Tervaert JW; Mulder AH; Kallenberg CG
    Adv Exp Med Biol; 1993; 336():253-6. PubMed ID: 8296614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
    Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
    J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic role of antineutrophil cytoplasmic autoantibodies.
    Ewert BH; Jennette JC; Falk RJ
    Am J Kidney Dis; 1991 Aug; 18(2):188-95. PubMed ID: 1651049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies.
    Reumaux D; Duthilleul P; Roos D
    Hum Immunol; 2004 Jan; 65(1):1-12. PubMed ID: 14700590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of ANCA-associated vasculitides.
    Kallenberg CG; Rarok A; Stegeman CA
    Cleve Clin J Med; 2002; 69 Suppl 2():SII61-3. PubMed ID: 12086267
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Wegener's granulomatosis with intravenous immunoglobulin.
    Richter C; Schnabel A; Csernok E; Reinhold-Keller E; Gross WL
    Adv Exp Med Biol; 1993; 336():487-9. PubMed ID: 8296662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis.
    Gross WL; Csernok E
    Curr Opin Rheumatol; 1995 Jan; 7(1):11-9. PubMed ID: 7718417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.
    Gaudin PB; Askin FB; Falk RJ; Jennette JC
    Am J Clin Pathol; 1995 Jul; 104(1):7-16. PubMed ID: 7611186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells.
    Mayet WJ; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1993 Dec; 94(3):440-6. PubMed ID: 7504599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in ANCA-associated vasculitides].
    Lamprecht P
    Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins.
    Tanaka S; Edberg JC; Chatham W; Fassina G; Kimberly RP
    J Immunol; 2003 Dec; 171(11):6090-6. PubMed ID: 14634123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes.
    Charles LA; Falk RJ; Jennette JC
    J Leukoc Biol; 1992 Jan; 51(1):65-8. PubMed ID: 1311014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.